–
Contineum Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.6
FY22:
−22.7
FY23:
16.1
FY24:
−50.9
FY25:
−68.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.3
FY22:
−21.7
FY23:
20.7
FY24:
−41.9
FY25:
−67.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.0
FY22:
−24.3
FY23:
23.2
FY24:
−42.3
FY25:
−60.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.0
FY22:
−24.3
FY23:
22.7
FY24:
−42.3
FY25:
−60.0
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.